Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1547 Inhibitors

Olr1547 inhibitors are a specialized class of chemical compounds designed to specifically target and inhibit the Olr1547 receptor, which is part of the olfactory receptor family within the G-protein coupled receptor (GPCR) superfamily. Olfactory receptors, including Olr1547, are responsible for detecting odorant molecules and initiating the signal transduction processes that lead to the perception of smells. The Olr1547 receptor, like other members of its family, operates by binding to specific ligands, which then trigger a series of intracellular signaling events. These events ultimately result in the activation of neural pathways associated with olfactory perception. Olr1547 inhibitors are designed to disrupt this binding process, either by directly competing with the natural ligands at the receptor's active site or by interacting with allosteric sites that cause conformational changes, reducing the receptor's ability to function effectively.

The development of Olr1547 inhibitors involves a detailed and systematic approach to optimizing various chemical properties, including binding affinity, selectivity, and stability. Researchers often use molecular modeling and docking simulations to predict how these inhibitors will interact with the Olr1547 receptor, providing insights into the receptor's structure and potential binding sites. High-throughput screening of chemical libraries is another key technique employed to identify lead compounds that show promising inhibitory activity against Olr1547. Once potential inhibitors are identified, they undergo structure-activity relationship (SAR) studies, where their chemical structures are refined to enhance potency and selectivity while minimizing off-target effects on other similar receptors. This refinement process may involve modifying the core chemical scaffold or altering functional groups to improve the interaction with the receptor. Additionally, considerations such as solubility, lipophilicity, and metabolic stability are crucial for ensuring that these inhibitors can function effectively under physiological conditions. Through this meticulous development process, Olr1547 inhibitors provide valuable tools for exploring the molecular mechanisms of olfactory receptor function and contribute to a broader understanding of GPCR-mediated signal transduction and its role in sensory perception.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Beta-adrenergic antagonist, might modulate GPCR activity potentially affecting Olr1547.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

Beta-adrenergic antagonist with alpha-1 blocking activity, could influence Olr1547 signaling.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$51.00
$171.00
$530.00
2
(1)

Alpha-2 adrenergic receptor antagonist, may affect GPCR signaling pathways related to Olr1547.

Labetalol

36894-69-6sc-484723
50 mg
$180.00
(0)

Combined alpha and beta blocker, could indirectly affect GPCR pathways including Olr1547.

Pindolol

13523-86-9sc-204847
sc-204847A
100 mg
1 g
$194.00
$760.00
(1)

Beta-adrenergic antagonist, may influence GPCR-mediated signaling pathways related to Olr1547.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Beta-adrenergic agonist, could indirectly affect Olr1547 through GPCR modulation.

Atropine

51-55-8sc-252392
5 g
$204.00
2
(1)

Muscarinic acetylcholine receptor antagonist, may influence GPCR signaling pathways including Olr1547.

Salmeterol

89365-50-4sc-224277
sc-224277A
10 mg
50 mg
$186.00
$562.00
1
(1)

Beta-2 adrenergic agonist, potentially affecting GPCR pathways related to Olr1547.

Alprenolol

13655-52-2sc-507469
50 mg
$130.00
(0)

Beta blocker, could indirectly influence GPCR signaling pathways including Olr1547.